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Summary Perioral dermatitis is an inflammatory facial skin disorder 
that predominantly affects women. It is rarely diagnosed in children. The 
etiology of perioral dermatitis is unknown; however, uncritical use of topi-
cal corticosteroids often precedes skin lesions. There is a written diag-
nostic work-up, differential diagnosis and treatment.
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IntroduCtIon
Perioral dermatitis (PD), rosacea-like derma-
titis, periorificial dermatitis, light-sensitive sebor-
rheic, chronic papulopustular facial dermatitis, 
papulopustular facial dermatitis, granulomatous 
perioral dermatitis, lupus-like perioral dermatitis, 
stewardess disease are synonyms for a chronic 
papulopustular facial dermatitis. It mostly occurs in 
young women. The clinical and histologic features 
of the lesions resemble those of rosacea. Patients 
require systemic and/or topical treatment, evalua-
tion of the underlying factors, and reassurance. In 
1957, Frumess and Lewis described cyclic derma-
titis affecting the skin of the perioral region, prin-
cipally among young females, by the term “light 
sensitive seborrhoeid” (1).
epIdemIology
PD predominantly affects women, who ac-
count for an estimated 90% of cases. The num-
ber of male patients is assumed to be increasing 
because of changes in their cosmetic habits. PD 
may occur but is rarely diagnosed in children (2, 
3). The vast majority of patients are women aged 
20-45 years (2).
pathogeneSIS
There may be more than one cause of PD 
(Table 1). The etiology of PD remains unknown; 
however, the uncritical use of topical steroids for 
minor skin alterations of the face often precedes 
the manifestation of the disease (5). The underly-
ing cause cannot be detected in all patients. Once 
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PD has developed, corticosteroid creams seem to 
help, but the disorder reappears when the treat-
ment is discontinued. In fact, PD usually comes 
back even worse than it was before the use of ste-
roid creams. The use of inhaled prescription ste-
roid sprays applied into the nose and mouth can 
also induce PD. Fluorinated toothpaste, overuse 
of heavy face creams and moisturizers, especially 
those with a petrolatum or paraffin base, and the 
vehicle isopropyl myristate are another common 
cause. Physical factors such as UV light, heat and 
wind worsen PD. Many investigators have consid-
ered that infections may cause PD. Microbiologic 
factors such as fusiform spirilla bacteria, Candida 
species, Demodex folliculorum and other fungi 
have been cultured from lesions. Their presence 
has no clear clinical relevance. Hormonal factors 
are suspected because of the premenstrual dete-
rioration observed. Oral contraceptives may also 
be a causative factor. Gastrointestinal disturbanc-
es such as malabsorption have been considered 
as well (5). 
ClInICal FeatureS
The disease is limited to the skin. Skin lesions 
occur as grouped follicular reddish papules, papu-
lovesicles and papulopustules on an erythema-
tous base with a possible confluent aspect (Figs 
1 and 2). The papules and pustules have mainly 
perioral locations. The predominant locations of 
PD lesions are the perioral area, nasolabial fold 
and lateral portions of lower eyelids. In an ex-
treme variant of the disease called lupus-like PD, 
granulomatous infiltrates have a yellowish aspect 
at diascopy. A frequently seen feature of PD is a 
border of normal skin separating lesional skin from 
the lips (Fig. 1). In the perioral type, discrete to 
moderate erythematous papules and pustules are 
found circularly, with a clear zone of 3-5 mm under 
the lower lip (Fig. 1).
Complications
Although PD is limited to the skin and is not 
a life-threatening condition, emotional problems 
may occur because of the disfiguring character of 
facial lesions and the possibly prolonged course 
of the disease. An initial rebound effect frequently 
occurs during the weaning of the steroid. This phe-
nomenon is rare when no underlying cause can be 
identified. Chronic course is not uncommon. The 
development of a lupoid dermal infiltrate is consid-
ered to be a feature of the maximal variant of the 
disease. The diagnosis is made on the basis of 
yellowish discoloration after diascopy. This entity 
is called lupus-like PD. Scarring may be a problem 
with the lupoid form of PD.
table 1. Etiology of perioral dermatitis
Drugs • Topical steroids• Inhaled prescription steroid sprays





Microbiologic factors • Fusiform spirilla bacteria
• Candida species
Miscellaneous factors
• Hormonal factors (oral contraceptives)
• Gastrointestinal disturbances (malabsorption)
• Emotional stress
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hIStopathology
Histopathologic appearances of the biopsies 
are similar to those of rosacea (4). Changes in 
the follicular epidermis are marked by most of the 
authors (6). They suggest that the disorder might 
be provoked by some external irritant (6). Biopsies 
should be taken from the chin or nasolabial groove 
and should include at least 1 papule. It must be ad-
mitted that the changes are not diagnostic. Usually 
the clinical picture and history of the disease de-
termine the diagnosis (5). Histopathologic exami-
nation of early papular lesions shows eczematous 
changes consisting of mild acanthosis, epidermal 
edema and parakeratosis. There are mainly ec-
tatic venules and lymphocytes, mild edema and 
sparse lymphatic perivascular infiltration. Usu-
ally, small peripheral areas of the hair follicles are 
edematous and are invaded by inflammatory cells. 
Sometimes follicular abscesses can be seen. The 
abscess cavity contains many polymorphonuclear 
leukocytes. Elastic fibers confirm the presence of 
elastic degeneration. Demodex mite can some-
times be demonstrated as an incidental finding. 
Examination of late papular lesions reveals diffuse 
hypertrophy of the connective tissue, accompa-
nied by hyperplasia of sebaceous follicles. In the 
dermis, occasionally there is discrete epithelioid 
cell granuloma of the noncaseating type with peri-
follicular predominance and scanty Langerhans 
giant cells. Caseating granulomata are character-
istic features of granulomatous PD (5).
dIagnoSIS
Clinical diagnosis
The diagnosis is made clinically. Usually good 
history of the disease, which reveals prolonged 
use of local corticosteroids or contact with other 
potential cause factors (Table 1) is enough. Clini-
cal picture is also characteristic. Predominantly 
there are erythematous papules and papulopus-
tules, usually localized in the perioral region. In 
more than 98% of cases, rebound phenomenon 
occurs (5). There is gradual disappearance of all 
symptoms, and relapses are rare unless cortico-
steroids are repeatedly administered. 
laboratory diagnosis
No laboratory abnormalities can be expected 
(4, 5). Prick tests and specific IgE testing against 
a mixture of aeroallergens have been used to test 
for skin barrier dysfunction. In a German study, PD 
table 2. Differential diagnosis of face rashes resembling perioral dermatitis
Rosacea
• usually centrofacial disease
• no comedones
• usually rhinophyma is present
Seborrheic dermatitis
• predominantly retroauricular, nasolabial region, eyebrow 
and scalp are affected
• main symptom is scaling
Acne vulgaris • comedones, papules, pustules, nodule, cysts• affects younger population
Facial demodicosis • mycology isolation of Demodex folliculorum)
Lupus miliaris disseminatus faciei • little scars are present• spontaneous regression
Polymorphous light eruption • itchy red papules, vesicles or plaques• after sun exposure
Contact dermatitis • border of the rash immerging into normal skin
Haber syndrome (familial rosacea-like 
dermatosis) 
• begins in childhood, intraepidermal epitheliomas, 
keratotic plaques and scars
Granulomatous periorificial dermatitis • in prepubertal children; yellow-brown papules limited to the perioral, perinasal and periocular regions
Figure 2. Perioral dermatitis. Diffuse erythema-
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patients experienced significantly increased tran-
sepidermal water loss compared with rosacea pa-
tients and a control group, which indicated a skin 
barrier function disorder. This type of testing is not 
routinely used (7).
differential diagnosis
PD is usually a straightforward clinical diag-
nosis (5). However, on differential diagnosis few 
facial skin diseases should be excluded (Table 2). 
Facial demodicosis (infestation with Demodexfol-
liculorum) clinically resembles PD and should be 
excluded, especially when anti-inflammatory ther-
apies fail. Patients who are prone to acne or ro-
sacea may experience worsening while undergo-
ing topical immunomodulating therapy (e.g., with 
tacrolimus ointment). Haber syndrome, or familial 
rosacea-like dermatosis with intraepidermal epi-
theliomas, keratotic plaques and scars, is a rare 
genodermatosis that begins in childhood. Granu-
lomatous periorificial dermatitis manifests most 
commonly in prepubertal children as yellow-brown 
papules limited to the perioral, perinasal and peri-
ocular regions. The condition is self-limiting and is 
not associated with systemic involvement.
treatment
The first step in therapeutic management 
should be discontinuation of all suspected topicals 
which, however, usually leads to relapse of skin 
lesion. One should insist on abandonment of all 
cosmetics, soaps, detergents, moisturizers, abra-
sives, adstrigents, day or night creams, skin con-
ditioners, etc. Washing with mild water only, using 
fingers is suggested by some authors. However, 
this “null (zero) therapy” is hard for many patients, 
so local neutral treatment such as neutral local 
creams and compresses (chamomile tea, physi-
ologic solution, etc.) have to be used. The duration 
of treatment is shorter with men because they give 
up the idea of ever being cured sooner than the 
women do. Sometimes the physician must provide 
a great deal of psychological support during office 
visits. Some of the patients develop corticosteroid 
dependence and therefore need medical help in-
cluding psychological support to break the habit 
(8). 
The patients have to be told that exacerbation 
is to be expected and that it may take many weeks 
to purify, and that the disease slowly regresses 
when exogenous factors are eliminated. Some 
investigators treat rebound phenomenon patients 
with hydrocortisone, because hydrocortisone cuts 
down the violence of the rebound reaction, while 
allowing the atrophic collagen to recover (9). Oth-
ers taper the dose of topical corticosteroids by re-
ducing the frequency of administration (10). 
The second factor in treatment is suppression 
of bacterial infection in hair follicles with systemic 
antibiotics. The population of Propionibacterium 
acnes within follicles is markedly elevated in pa-
tients who apply local corticosteroids. Propionibac-
terium acnes  inflame follicles directly by producing 
agents chemotactic for polymorphonuclear leuko-
cytes. Fusobacteria are often found in PD induced 
by fluorinated corticosteroids. Besides these two 
bacteria, in facial dermatoses induced by local 
corticosteroids one can find gram-negative bacte-
ria, staphylococci or sometimes even streptococ-
ci. Preference is given to lipophilic tetracyclines 
like oxytetracycline, monocycline or doxycycline, 
100-250 mg per day for 3-4 months, rarely longer. 
To prevent poststeroid flare, oral tetracyclines are 
contraindicated in children younger than 11 years. 
Acceptable treatment for children includes oral as 
well as topical erythromycin and topical metroni-
dazole. If there is no response to full dose of tet-
racyclines, one may have to resort to isotretinoin. 
Quite low doses are effective; usually 5 mg as a 
simple daily dose for about 3 months; even 2-3 
mg/day may be helpful. Precautions must be tak-
en in women of childbearing potential. In less se-
vere cases only, a neutral local therapy combined 
with anti-inflammatory agents can be used, mostly 
local erythromycin and metronidazole, neomycin, 
clindamycin and oxytetracycline administered in a 
nongreasy base (e.g., gel, lotion or cream). They 
have both moisturizing and antibiotic effects. The 
response of PD to metronidazole is the result of 
the drug’s anti-inflammatory and immunosuppres-
sive effects rather than the direct antimicrobial 
action (12). Topical antiacne medications such as 
adapalene and azelaic acid have been used (13) 
in open studies. Ointments should be avoided. 
In severe cases of PD, local immunomodulatory 
creams such as tacrolimus and pimecrolimus can 
be used (14,15).
Topical antipruritics containing no corticoste-
roids, such as liquid pramoxine hydrochloride, of-
fer excellent symptomatic relief. The response to 
local treatment with sulfur, resorcin and ichthyol 
was very unsatisfactory.
ConCluSIon
PD has become a quite common facial derma-
titis nowadays because of the inappropriate use of 
topical steroids on the face. Various environmen-
tal sensitivities have been reported. The link to 	
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rosacea is not certain but the two disorders occur 
in the same population and both respond to the 
same drugs.
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